Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases

Journal of Medicinal Chemistry
Jakob S PallesenAnders Bach

Abstract

The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has a protective effect against oxidative stress and plays a major role in inflammation and central nervous system (CNS) diseases. Inhibition of the protein-protein interaction (PPI) between Nrf2 and its repressor protein, Kelch-like ECH-associated protein 1 (Keap1), leads to translocation of Nrf2 from the cytosol to the nucleus and expression of detoxifying antioxidant enzymes. To date, several non-covalent small-molecule Keap1-Nrf2 inhibitors have been identified; however, many of them contain carboxylic acids and are rather large in size, which likely prevents or decreases CNS permeability. This Perspective describes current small-molecule Keap1-Nrf2 inhibitors with experimental evidence for the ability to inhibit the Keap1-Nrf2 interaction by binding to Keap1 in a non-covalent manner. Binding data, biostructural studies, and biological activity are summarized for the inhibitors, and their potential as CNS tool compounds is discussed by analyzing physicochemical properties, including CNS multiparameter optimization (MPO) scoring algorithms. Finally, several strategies for identifying CNS-targeting Keap1 inhibitors are described.

References

Jul 1, 1982·Journal of Medicinal Chemistry·S D Nelson
Aug 9, 2002·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Makoto KobayashiMasayuki Yamamoto
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Albena T Dinkova-KostovaPaul Talalay
Feb 5, 2003·Drug Discovery Today·Gilbert M Rishton
Aug 3, 2004·Nature Reviews. Drug Discovery·David C ReesRobin Carr
Dec 2, 2004·Molecular and Cellular Biology·Donna D ZhangMark Hannink
Nov 6, 2007·Journal of the American Society for Mass Spectrometry·Yan LuoRichard B van Breemen
May 1, 2008·The AAPS Journal·Jarkko RautioJouko Savolainen
Jun 19, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Barbara PavanSilvia Vertuani
Sep 26, 2008·BMC Bioinformatics·David LagorceBruno O Villoutreix
May 13, 2009·Journal of Chemical Information and Modeling·Thomas A Halgren
Jul 25, 2009·Antioxidants & Redox Signaling·Rao Muralikrishna Adibhatla, James Franklin Hatcher
Sep 8, 2009·Toxicology and Applied Pharmacology·Mi-Kyoung Kwak, Thomas W Kensler
Nov 19, 2009·Journal of Translational Medicine·Shaheen E LakhanMagdalena Hofer
Sep 18, 2010·Molecular Pharmaceutics·Dikran SarkoWalter Mier
Feb 8, 2011·Free Radical Biology & Medicine·Tomasz M Stępkowski, Marcin K Kruszewski
Mar 19, 2011·Biochemical and Biophysical Research Communications·Jing ZhaoPramod K Dash
Mar 24, 2011·Future Medicinal Chemistry·Jonathan B Baell
Oct 28, 2011·Nature Neuroscience·Costantino Iadecola, Josef Anrather
Nov 24, 2011·Free Radical Biology & Medicine·Rowena HancockGeoff Wells
Feb 4, 2012·Acta Pharmacologica Sinica·Xuan ZhangZhi-rong Zhang
Feb 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Anders BachKristian Strømgaard
May 3, 2012·Medicinal Research Reviews·Sadagopan MageshLongqin Hu
May 5, 2012·PloS One·Yun LiYuesheng Zhang
Jun 16, 2012·Biochemistry·Duncan E ScottChris Abell
Feb 28, 2013·Journal of Hematology & Oncology·Xinyuan LiXiao-feng Yang
Apr 9, 2013·Bioorganic & Medicinal Chemistry Letters·Longqin HuBenito Munoz
Apr 26, 2013·Organic & Biomolecular Chemistry·Rowena HancockGeoff Wells
May 8, 2013·Bioorganic & Medicinal Chemistry·Douglas MarcotteLaura Silvian
Aug 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Liam BairdAlbena T Dinkova-Kostova
Nov 12, 2013·The New England Journal of Medicine·Dick de ZeeuwUNKNOWN BEACON Trial Investigators
Dec 25, 2013·Molecular and Cellular Biology·Toshiaki FukutomiMasayuki Yamamoto
Feb 1, 2014·Nature Reviews. Drug Discovery·Andrew L HopkinsCharles H Reynolds

❮ Previous
Next ❯

Citations

Jan 18, 2020·Future Medicinal Chemistry·Hongzhi LinHaopeng Sun
Jan 11, 2020·Expert Opinion on Therapeutic Patents·Haishan ZhouZhengyu Jiang
Mar 11, 2020·Nature·Christoph GorgullaHaribabu Arthanari
May 14, 2020·Natural Product Reports·Donna D Zhang, Eli Chapman
Jul 2, 2020·Cancers·Dilip NarayananDennis Özcelik
Jan 6, 2019·Nature Reviews. Drug Discovery·Antonio CuadradoAlbena T Dinkova-Kostova
May 12, 2020·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Sumi Lee, Longqin Hu
Jul 13, 2020·Chemical Biology & Drug Design·Yuyu XuChenghong Sun
Aug 15, 2020·Antioxidants & Redox Signaling·Tiago L DuarteHal Drakesmith
Feb 11, 2021·Journal of Computational Chemistry·Fernando Jiménez-GrávalosAlexander S Novikov
Apr 16, 2021·Journal of Medicinal Chemistry·Elisa SassettiLuca Laraia
Jun 3, 2021·International Journal of Molecular Sciences·Christoph GorgullaHaribabu Arthanari
Dec 19, 2020·Journal of Medicinal Chemistry·Fabio BegniniJan Kihlberg
May 22, 2020·ACS Medicinal Chemistry Letters·Jesus M OntoriaSteven Harper
Sep 15, 2021·Journal of the American Chemical Society·Jieli WeiJian Jin
Jan 16, 2022·Bioorganic & Medicinal Chemistry Letters·Weiwei HuangLei Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here